Market Research Report
Carboplatin Market, By Indication (Ovarian cancer, Small cell lung cancer and Others) and by Region (North America, Europe, Asia Pacific and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
|Published by||AnalystView Market Insights||Product code||825256|
|Published||Content info||159 Pages
Delivery time: 2-3 business days
|Carboplatin Market, By Indication (Ovarian cancer, Small cell lung cancer and Others) and by Region (North America, Europe, Asia Pacific and RoW) - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025|
|Published: April 1, 2019||Content info: 159 Pages||
The carboplatin market is estimated to represent a global market of USD xx billion by 2017 with growth rate of xx%.
Carboplatin is used in treatment of ovarian cancer as well as many other cancers such as small cell lung cancer, breast cancer, germ cell tumours. During the treatment, in some cases the cancer becomes resistant to carboplatin and other platinum based drugs such as Cis Platin. This condition is known as platinum resistant cancer. Pipeline studies are being conducted in which other drugs are used to bring back sensitivity of cancer to platinum based drugs.
Ovarian cancer dominates the global carboplatin market over the forecast period. Increase in reoccurrence rate of ovarian cancer is expected to boost the market for carboplatin, as many medical practitioners preferred chemo therapy over surgery and radiation therapy. Furthermore, carboplatin more tolerable in geriatric patients compared to its counterpart and is more effective than carboplatin which in turn may increase the market for carboplatin in the study period. Increasing use of carboplatin to treat other form of cancer such as breast and lung is expected to propel the market for carboplatin in near future.
In terms of revenue, Asia Pacific held the larger market share in 2016. Increasing incidence of cancer, increase in healthcare spending and growing contract manufacturing service in the region owing to low cost of manufacturing are the main factor driving the growth of carboplatin market over the forecast period. Moreover, presence of favorable government initiatives and increase in contract research and development service in China and India is expected to boost the market for carboplatin in the region.
The market size and forecast for each segment and sub-segments has been considered as below:
The scope of this report covers the market by its major segments, which include as follows: